A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
The DOI matches its Crossref record; 245 of the 249 references it cites were found in a registry or an index.
Abstract
Up to 15% of patients with essential hypertension have inappropriate regulation of aldosterone; although only a minority have distinct adrenal tumors, recent evidence shows that mineralocorticoid receptor activation contributes to the age-related blood pressure rise and illustrates the importance of aldosterone in determining cardiovascular risk. Aldosterone also has a major role in progression and outcome of ischemic heart disease. These data highlight the need to understand better the regulation of aldosterone synthesis and its action. Aldosterone effects are mediated mainly through classical nuclear receptors that alter gene transcription. In classic epithelial target tissues, signaling mechanisms are relatively well defined. However, aldosterone has major effects in nonepithelial tissues that include increased synthesis of proinflammatory molecules and reactive oxygen species; it remains unclear how these effects are controlled and how receptor specificity is maintained. Variation in aldosterone production reflects interaction of genetic and environmental factors. Although the environmental factors are well understood, the genetic control of aldosterone synthesis is still the subject of debate. Aldosterone synthase (encoded by the CYP11B2 gene) controls conversion of deoxycorticosterone to aldosterone. Polymorphic variation in CYP11B2 is associated with increased risk of hypertension, but the molecular mechanism that accounts for this is not known. Altered 11beta-hydroxylase efficiency (conversion of deoxycortisol to cortisol) as a consequence of variation in the neighboring gene (CYP11B1) may be important in contributing to altered control of aldosterone synthesis, so that the risk of hypertension may reflect a digenic effect, a concept that is discussed further. There is evidence that a long-term increase in aldosterone production from early life is determined by an interaction of genetic and environmental factors, leading to the eventual phenotypes of aldosterone-associated hypertension and cardiovascular damage in middle age and beyond. The importance of aldosterone has generated interest in its therapeutic modulation. Disadvantages associated with spironolactone (altered libido, gynecomastia) have led to a search for alternative mineralocorticoid receptor antagonists. Of these, eplerenone has been shown to reduce cardiovascular risk after myocardial infarction. The benefits and disadvantages of this therapeutic approach are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism (PA) is associated with increased risk for dysglycemia.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [7]
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
Payne, A. H., & Hales, D. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0030 · Cited by 1,766
Cited by
Items 101–194 of 194
The relationship between vitamin D deficiency and coronary artery ectasia
Demir, M., Demir, C., & Keçeoğlu, S. (2014) · Advances in Interventional Cardiology · doi:10.5114/pwki.2014.46764 · Cited by 11
Plasma steroid profiling and response to trophins to illustrate intra-adrenal dynamics
McManus, F., Fräser, R., Davies, E., Connell, J. M. C., & Freel, E. M. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0561 · Cited by 11
“…within CYP11B1 (11b-hydroxylase), CYP11B2 (aldosterone synthase) and CYP17A1 (17a-hydroxylase) also affect efficiency to an extent that is probably clinically significant (Barr et al. 2007, Connell et al. 2008, Freel et al. 2008) (L Diver, J M C Connell & E Davies 2014, unpublished observations).”
BackgroundSelf-citationWellman, K., Fu, R., Baldwin, A., Rege, J., Murphy, E., Rainey, W. E., & Mukherjee, N. (2021) · Cells · doi:10.3390/cells10092376 · Cited by 11
Louat, A., Dwikat, M. F., Nounou, M. V., Abdulhamid, S. M., Abdelaziz, A., Ibrahim, A. M., Sabouret, P. F., & Elhadi, M. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e41 · Cited by 10
“Due to the high sequence homology between CYP11B2 and CYP11B1 genes, these agents also inhibited 11 β -hydroxylase, thereby impairing cortisol synthesis and increasing the risk of adrenal insufficiency [13,14].”
Aldosterone, the Mineralocorticoid Receptor and Mechanisms of Cardiovascular Disease
Young, M. J., & Adler, G. K. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.003 · Cited by 10
Noro, E., Yokoyama, A., Kobayashi, M., Shimada, H., Suzuki, S., Hosokawa, M., Takehara, T., Parvin, R., Shima, H., Igarashi, K., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051406 · Cited by 11
“21-OHase, and AS (aldosterone synthase) [4].”
11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life
Ancelin, M., Norton, J. L., Ritchie, K. A., Chaudieu, I., & Ryan, J. L. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.190177 · Cited by 11
Current Research of the RAS in Diabetes Mellitus
Leung, P. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9060-7_8 · Cited by 11
Zhao, L., Yang, W., Ji, W., Pan, Q., Yang, J., & Cao, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27472 · Cited by 9
“Aldosterone regulates sodium resorption and fluid levels [55], and high levels of cortisol are associated with type 2 diabetes [56,57].”
Hypertension artérielle endocrine
Amar, L., Lussey‐Lepoutre, C., Bobrie, G., & Plouin, P. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.08.015 · Cited by 13
Chacko, S. J., Pauwaa, S., Barengolts, E. I., Ciubotaru, I., & Kansal, M. M. (2015) · Echocardiography · doi:10.1111/echo.13159 · Cited by 9
“Inhibiting RAAS and PTH also has positive effects on blood pressure regulation, which ultimately impacts left atrial volume.(29) It is notable that while increases in left atrial volume were attenuated, Doppler measurements of diastolic function did not significantly change throughout the study.”
BackgroundDevelopment of a risk-prediction model for primary aldosteronism in veterans with hypertension
Ginzberg, S. P., Kalva, S., Wirtalla, C. J., Passman, J. E., Cohen, D. L., Cohen, J. B., & Wachtel, H. (2023) · Surgery · doi:10.1016/j.surg.2023.04.063 · Cited by 8
Hung, C., the TAIPAI Study Group, Wu, X.-M., Chen, C., Chen, Y.-H., Wu, V., Liao, C., Chang, Y., Yen, R., Lu, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17505 · Cited by 8
Primary Aldosteronism, Aldosterone, and Extracellular Vesicles
Carvajal, C. A., Tapia-Castillo, A., Pérez, J. A., & Fardella, C. (2021) · Endocrinology · doi:10.1210/endocr/bqab240 · Cited by 8
Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
Romero, D. G., & Cardozo, L. L. Y. (2016) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.129 · Cited by 11
“The steroid hormone aldosterone is the main mineralocorticoid and is synthetized by the zona glomerulosa of the adrenal gland cortex [2,3].”
BackgroundIzzo, J. L., Hong, M., Hussain, T., & Osmond, P. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13567 · Cited by 7
Izzo, J. L., Hong, M., Hussain, T., & Osmond, P. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13597 · Cited by 7
Tapia-Castillo, A., Carvajal, C. A., Pérez, J. A., & Fardella, C. (2022) · Endocrine · doi:10.1007/s12020-022-03103-x · Cited by 8
McQuarrie, E. P., Freel, E. M., Mark, P. B., Fraser, R., Patel, R. K., Dargie, H., Connell, J., & Jardine, A. G. (2012) · Clinical Science · doi:10.1042/cs20120015 · Cited by 7
Self-citationBu, X., Sun, F., Zhang, H., Liu, X., Zhao, Z., He, H., Li, Y., Yan, Z., & Zhu, Z. (2022) · Journal of Diabetes Research · doi:10.1155/2022/8932133 · Cited by 6
Cushing’s Disease Presented by Reversible Dilated Cardiomyopathy
Aydoğan, B. İ., Gerede, D. M., Canpolat, A. G., & Erdoğan, M. F. (2015) · Case Reports in Cardiology · doi:10.1155/2015/980897 · Cited by 6
“Cortisol leads to increased catecholamine response in myocardium and activates reninangiotensin axis [12].”
BackgroundMacKenzie, S. M., Freel, E. M., Connell, J., Fraser, R., & Davies, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030579 · Cited by 6
“The renin-angiotensin system (RAS) and raised extracellular potassium concentration are the principal stimulators of CYP11B2 expression; ACTH is generally regarded as having only a short-lived effect, of far less physiological significance than the other factors [3].”
BackgroundInfluentialSelf-citation(2013) · Circulation · doi:10.1161/cir.0b013e31829ab2fb · Cited by 6
Feline primary hyperaldosteronism: an emerging endocrine disease
Bento, D. D., Zahn, F. S., Duarte, L. C., & Machado, L. H. D. A. (2016) · Ciência Rural · doi:10.1590/0103-8478cr20141327 · Cited by 5
THE IMPORTANCE OF RENIN‐ANGIOTENSIN BLOCKADE IN PATIENTS WITH CARDIO‐RENAL DISEASE
Benavente, D., Chue, C. D., & Ferro, C. J. (2010) · Journal of Renal Care · doi:10.1111/j.1755-6686.2010.00166.x · Cited by 6
Ingram, M. C., & Fraser, R. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.76 · Cited by 4
Self-citationRusbridge, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-13706-8_14 · Cited by 4
Role of Genetic Variation in Regulation of Aldosterone Biosynthesis
Alvarez‐Madrazo, S., Connell, J., & Freel, E. M. (2010) · Endocrine development · doi:10.1159/000321229 · Cited by 6
Self-citationVarious actions of aldosterone: The kidney and beyond…
Lombès, M. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.011 · Cited by 4
Duquet, L., Lefebvre, L., Lemaire‐Paquette, S., Malick, M., Mallet, P., & St‐Jean, M. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae209 · Cited by 3
Long, K. C., & Azizan, E. A. B. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1736534 · Cited by 3
Kumar, R. (2021) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2021.113780 · Cited by 3
Kelly, T. N., & He, J. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398397-8.00010-1 · Cited by 3
Benavente, D., Mrcp, C. D. C., & Ferro, C. J. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70567-8 · Cited by 3
MicroRNAs in Aldosterone Production and Action
MacKenzie, S. M., van Kralingen, J. C., Martin, H., & Davies, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87226 · Cited by 3
“Excess secretion of aldosterone, as in primary aldosteronism (PA), leads to severe hypertension with markedly increased risk of myocardial infarction, stroke and left ventricular hypertrophy [1].”
BackgroundSelf-citationPilz, S., Tomaschitz, A., & März, W. (2009) · Journal of Laboratory Medicine · doi:10.1515/jlm.2009.032 · Cited by 4
Kang, S., Lee, H., Lee, E., Kim, M., & Kim, I. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12614 · Cited by 4
The role of radiologic studies in the evaluation and management of primary hyperaldosteronism
Miller, B. S. (2009) · Surgery · doi:10.1016/j.surg.2009.10.030 · Cited by 3
MicroRNAs in aldosterone production and action
MacKenzie, S. M., Birch, L. A., Lamprou, S., Rezvanisanijouybari, P., Fayad, M., Zennaro, M., & Davies, E. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.07.001 · Cited by 3
Self-citationMetabolic syndrome and primary aldosteronism: time for reappraisal?
Fallo, F., & Sonino, N. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.76 · Cited by 2
Aldosterone and the cardiovascular system: a dangerous association
Cachofeiro, V., López‐Andrés, N., Miana, M., Martín‐Fernández, B., Heras, N. D. L., Martínez‐Martínez, E., Lahera, V., & Fortuño, M. A. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.057 · Cited by 3
“However, it is important to mention that some contradictory results have questioned the local production of aldosterone in the heart (19).”
BackgroundHormonal Mechanisms in Atherosclerosis
Dobrescu, M., Păun, D. L., Grigorie, D., & Poiană, C. (2020) · Internal Medicine · doi:10.2478/inmed-2020-0114 · Cited by 2
Arnaiz‐Villena, A., Cruz‐Robles, D., Vargas‐Alarcón, G., Lopez-Pacheco, F., Rodríguez-Pérez, J. M., Muñiz, E., Arriaga, J. C., Granados, J., Escobedo, G., & Fragoso, J. M. (2016) · International Journal of Modern Anthropology · doi:10.4314/ijma.v1i9.3 · Cited by 1
Neonatal lipopolysaccharide administration causes long-term changes in mouse immunosteroids
Salehzadeh, M., Mazurenko, A., & Soma, K. K. (2026) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00135.2025 · Cited by 1
Antihypertensive Role of Kidney: Focus on Tissue Kallikreins
Mandal, A., Chakraborti, T., & Chakraborti, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-6141-7_26 · Cited by 1
Safety and Efficacy of Eplerenone in the Management of Essential Hypertension
McManus, F., & Connell, J. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2211 · Cited by 1
Self-citationCoexistence of two causes of secondary hypertension in a single patient
Vallejo‐Vaz, A. J., Grilo, A., Villar, J. R., Domínguez-Hidalgo, L., & Stiefel, P. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2013.04.001 · Cited by 1
Recent advances in the diagnosis and molecular aspects of adrenal-endocrine hypertension.
Yamada, M., & Mori, M. (2012) · PubMed · Cited by 1
Serum aldosterone and coronary artery disease
Nesarhosseini, V., Rasooli, M., & Taghipour, M. (2017) · Vascular Diseases and Therapeutics · doi:10.15761/vdt.1000107 · Cited by 1
“proposed that circulating glucocorticoid levels might activate the mineralocorticoid receptor [18,19].”
BackgroundMacKenzie, S. M., Cat, A. N. D., van Kralingen, J. C., & Davies, E. (2019) · Springer eBooks · doi:10.1007/978-3-030-16481-2_10 · Cited by 1
Self-citationApparent Mineralocorticoid Excess
Carvajal, C. A., Tapia-Castillo, A., Uslar, T., & Fardella, C. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_11 · Cited by 1
Aldosterone and the cardiovascular complications of chronic kidney disease
Powell, J. R. (2011) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Aldosterone and Cardiovascular Diseases
Tomaschitz, A., & Pilz, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_12
Madlala, H. P. (2012) · ResearchSpace (University of KwaZulu-Natal)
Die Rolle von Aldosteron im Knochenstoffwechsel
Tomaschitz, A., Kienreich, K., Fahrleitner‐Pammer, A., & Pilz, S. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Burgaz, A. (2011) · Figshare
Azizi, M., Monge, M., Lorthioir, A., Bobrie, G., & Amar, L. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328364bcdf · Cited by 1
Cure for a resistant hypertension case that required seven drugs for blood pressure control
Stiefel, P., Grilo, A., Domínguez-Hidalgo, L., & Villar, J. R. (2012) · Hypertension Research · doi:10.1038/hr.2012.21
Alvarez‐Madrazo, S. (2010) · Enlighten: Theses (The University of Glasgow)
Primary aldosteronism: an update
Freel, E. M., & Connell, J. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.10
Self-citationMedical management of primary aldosteronism
Connell, J. M. C. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.013
Self-citation1) Biochemistry and Physiological Function of Aldosterone
Takeda, Y. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.2150
Hiperaldosteronismo em Felinos
Canuto, F. J. C., Neto, J. L. D. S., & Costa, P. P. C. (2016) · Revista de Ciência Veterinária e Saúde Pública · doi:10.4025/revcivet.v3i1.32568
Values Over a Broad Range Aldosterone/Renin Ratio Determines Peripheral and Central Blood Pressure
Dobnig, H., Renner, W., Boehm, B. O., Fahrleitner‐Pammer, A., März, W., Pilz, S., Ritz, E., & Scharnagl, H. (2011)
Tkhorenko, B. A., Цепокина, А. В., Тришкина, Н. Н., Lavryashina, M. B., & Ponasenko, A. V. (2019) · Russian Journal of Genetics · doi:10.1134/s1022795419060176
“Elevated levels of progesterone reduce the sodium saving function of aldosterone, and MR dysregulation may contribute to the development of cardiovascular diseases, including AH [42], since the aldosterone/MR complex plays a central role in regulating blood pressure [43].”
重度のうっ血性心不全を来したクッシング病の1例(Congestive heart failure due to Cushing’s disease)
龍, 津., 薫, 栗., & 伸朗, 志. (2017) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12230
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832c937e
(2013) · Circulation · doi:10.1161/cir.0b013e318294334d
Primary aldosteronism and other steroid-related causes of endocrine hypertension
Connell, J., & Freel, E. M. (2011) · doi:10.1093/med/9780199235292.003.0570
Self-citationApparent Mineralocorticoid Excess
Carvajal, C. A., Tapia-Castillo, A., Uslar, T., & Fardella, C. (2022) · Endocrinology · doi:10.1007/978-3-030-44628-4_11-1 · Cited by 1
A rare case of Cushing’s syndrome presenting with dilated cardiomyopathyPreprint
Erdoğan, B. T., Helvacı, B. C., Housseın, M., Postacı, A., Kafes, H., Seyrek, F. N. Ç., Aydın, C., Ersoy, R., Topaloğlu, O., & Çakır, B. (2023) · Research Square · doi:10.21203/rs.3.rs-2849040/v1
Change in postoperative cardiac structure and functions in young women with Cushing’s syndrome
Yamane, A., Kato, M., MATSUI, S., Nagai, M., Kagawa, E., Kunita, E., & Oda, N. (2023) · Choonpa Igaku · doi:10.3179/jjmu.jjmu.a.245
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch3
Vitamin D Deficiency in Premenopause: Endothelial and Diastolic Functions With HyperparathyroidismPreprint
Akhan, O., & Doğduş, M. (2024) · doi:10.22541/au.170664953.36321001/v1
Patterns of aldosterone, renin level and aldosterone/renin ratio in young hypertensive patients
Saha, S. K., Moni, T. T., & Kadir, M. R. (2024) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20240827
Characterization of a Biochemical Mouse Model of Primary Aldosteronism for Thermal TherapiesPreprint
Timmerman, S. A., Mullen, N., TAYLOR, A. E. R., Gilligan, L. C., Pyle, M. M., Shrestha, T. B., Šebek, J., Highland, M. A., Challapalli, R. S., Arlt, W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.07.592955
Vitamin D3 Deficiency's Impact on Atrial Fibrillation in Hyperthyroidism Patients
Dhefer, I. H. (2024) · Diyala Journal of Medicine · doi:10.26505/djm.26028011119 · Cited by 1
Infraspinatus muscle necrosis in a cat with primary hyperaldosteronism
Otani, G., & Ohta, H. (2024) · Journal of Feline Medicine and Surgery Open Reports · doi:10.1177/20551169241282737
Aldosterone: Synthesis and regulation
Álvarez-García, E., & Bello-Rego, M. (2025) · Vitamins and hormones · doi:10.1016/bs.vh.2025.11.001
Neue Medikamente in der Hypertensiologie
Kintscher, U., & Kreutz, R. H. (2011) · Der Nephrologe · doi:10.1007/s11560-011-0546-2
Salehzadeh Moghadami, M. (2024) · cIRcle (University of British Columbia) · doi:10.14288/1.0445135
Application of thermal therapies and remotely targeted drug delivery systems to treat cancer
Keck, S. (2023) · K-State Research Exchange (Kansas State University)
Mineralocorticoid receptor signaling in Triple-negative Breast Cancer
Posani, S. H. (2023) · University of Minnesota Digital Conservancy (University of Minnesota)
El hiperaldosteronismo primario en la especie felina.
Martínez Mas, I., & Montoya, A. L. (2023) · Zaguan (Universidad de Zaragoza)
Ma, X., Lin, X., Liu, N., Zeng, Y., Guo, L., Feng, Q., Wu, M., Cai, F., Hu, Y., Wang, Y., et al. (2026) · Endocrine · doi:10.1007/s12020-025-04492-5
Aldosterone—an Intermediate Factor Linking Psychosocial Stress to Essential Hypertension
Gideon, A. (2024) · KOPS (University of Konstanz) · Cited by 1
Les cibles moléculaires du récepteur minéralocorticoïde dans le coeur
Gravez, B. (2015) · theses.fr (ABES) · doi:10.70675/0a6faa81z3681z4d47z8c5bz6a63e97dde84
The Silent Long-Term Damage of Resistant Hypertension: A Clinical Case Report
Erarslan, S., Gode, C. Y., & Kilit, T. P. (2026) · Turkish Journal of Internal Medicine · doi:10.46310/tjim.1884135
Metadata
- Authors
- Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E.
- Affiliations
- British Heart Foundation (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-02-21
- Volume
- 29
- Issue
- 2
- Pages
- 133-154
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1977973738
- Semantic Scholar
- a5e9ead66dd474017e77ece0053f5ef285c2b773
- Cited by
- 182
- References
- 249
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 10 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 10 · 2016: 13 · 2015: 5 · 2014: 13 · 2013: 11 · 2012: 20
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Heart Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- aldosterone excess, essential hypertension, mineralocorticoid receptor, cardiovascular risk, aldosterone synthase, CYP11B2, CYP11B1, 11β-hydroxylase, ischemic heart disease, proinflammatory molecules, reactive oxygen species, genetic and environmental factors, spironolactone, eplerenone, mineralocorticoid receptor antagonists, myocardial infarction
- MeSH terms
- Aldosterone, Animals, Cardiovascular Physiological Phenomena, Humans, Hyperaldosteronism, Hypertension, Renal, Renin-Angiotensin System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.